Monograph Details
|
|
Immune System
> Immunization
|
|
JE-VAX |
| Manufacturer |
|
Sanofi Pasteur, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Japanese encephalitis vaccine. |
| Generic Name |
|
Japanese encephalitis virus vaccine inactivated; pwd for SC inj after reconstitution; contains gelatin, formaldehyde, and rodent and neural proteins; preserved with thimerosal. |
| Indications |
|
Japanese encephalitis immunization (see current CDC advisories for recommendations). |
| Adults and Children |
|
<1yr: not recommended; 1–3yrs: each dose is 0.5mL SC; ≥7yrs: each dose is 1mL SC. Primary series: 3 doses on days 0, 7, and 30. Booster dose 2 years later. |
| Contraindications |
|
Generalized urticaria or angioedema to a previous dose. |
| Precautions |
|
Observe for 30 minutes after vaccination. Ensure access to medical care for 10 days after dose due to possible delay generalized urticaria. History of urticaria. Have epinephrine (1:1000) available. Elderly. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Avoid excessive alcohol for 48 hours. Concomitant vaccines (see literature). |
| Adverse Reactions |
|
Local reactions (eg, tenderness, edema), fever, headache, malaise, chills, GI upset, abdominal pain, urticaria, angioedema, wheezing. |
| How Supplied |
Single-dose vials—3 (w. diluent)
Multi-dose vial (w. diluent)—1 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
